Literature DB >> 26987852

Neurogenesis in Stroke Recovery.

Seong-Ho Koh1,2, Hyun-Hee Park3.   

Abstract

Stroke, resulting from limited blood flow to the brain, is one of the most important causes of morbidity and mortality worldwide. Stroke is classified as ischemic, due to lack of blood flow, or hemorrhagic, due to bleeding. Because 87 % of strokes are classified as ischemic, this type will be the predominant focus of this review. Except for thrombolytic therapy, there is no established treatment to reduce the neurological deficits caused by ischemic stroke. Therefore, it is necessary to develop new therapeutic strategies designed to improve neurological functions after ischemic stroke. Recently, therapies to enhance neurogenesis after ischemic stroke have been investigated. However, these approaches have not led to successful clinical outcomes. This review addresses the pathophysiology of stroke, neurogenesis after stroke, and how to stimulate these processes based on the current literature. Finally, ongoing clinical trials to improve neurological functions after stroke by enhancing neurogenesis are discussed in this review.

Entities:  

Keywords:  Neural stem cells; Neurogenesis; Stroke

Mesh:

Year:  2016        PMID: 26987852     DOI: 10.1007/s12975-016-0460-z

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  91 in total

1.  Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells.

Authors:  S J Morrison; S E Perez; Z Qiao; J M Verdi; C Hicks; G Weinmaster; D J Anderson
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

Review 2.  Identification of neural stem cells in the adult vertebrate brain.

Authors:  Arturo Alvarez-Buylla; Bettina Seri; Fiona Doetsch
Journal:  Brain Res Bull       Date:  2002-04       Impact factor: 4.077

3.  Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex.

Authors:  Chi Bun Chan; Xia Liu; Sompol Pradoldej; Chunhai Hao; Jie An; Manuel Yepes; Hongbo R Luo; Keqiang Ye
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

4.  Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model.

Authors:  Seung-Wan Yoo; Sung-Soo Kim; Soo-Yeol Lee; Hey-Sun Lee; Hyun-Soo Kim; Young-Don Lee; Haeyoung Suh-Kim
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

Review 5.  Role of neurotrophic factors in neuronal development.

Authors:  C E Henderson
Journal:  Curr Opin Neurobiol       Date:  1996-02       Impact factor: 6.627

6.  Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus.

Authors:  M A Aberg; N D Aberg; H Hedbäcker; J Oscarsson; P S Eriksson
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

Review 7.  Cryptogenic stroke: time to determine aetiology.

Authors:  F Guercini; M Acciarresi; G Agnelli; M Paciaroni
Journal:  J Thromb Haemost       Date:  2008-01-15       Impact factor: 5.824

8.  Proliferative zones of postnatal rat brain express epidermal growth factor receptor mRNA.

Authors:  K B Seroogy; C M Gall; D C Lee; H I Kornblum
Journal:  Brain Res       Date:  1995-01-23       Impact factor: 3.252

9.  Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke.

Authors:  Li Zhang; Michael Chopp; Dieter H Meier; Stefan Winter; Lei Wang; Alexandra Szalad; Mei Lu; Min Wei; Yisheng Cui; Zheng Gang Zhang
Journal:  Stroke       Date:  2013-05-21       Impact factor: 7.914

10.  Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats.

Authors:  B Chen; X-Q Gao; C-X Yang; S-K Tan; Z-L Sun; N-H Yan; Y-G Pang; M Yuan; G-J Chen; G-T Xu; K Zhang; Q L Yuan
Journal:  Brain Res       Date:  2009-06-09       Impact factor: 3.252

View more
  61 in total

1.  Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Authors:  Paul A Lapchak; Jacqueline M Lara; Paul D Boitano
Journal:  Transl Stroke Res       Date:  2017-04-12       Impact factor: 6.829

2.  GSK-3β Inhibition Induced Neuroprotection, Regeneration, and Functional Recovery After Intracerebral Hemorrhagic Stroke.

Authors:  Yingying Zhao; Zheng Zachory Wei; James Ya Zhang; Yongbo Zhang; Soonmi Won; Jinmei Sun; Shan Ping Yu; Jimei Li; Ling Wei
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

Review 3.  Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways.

Authors:  Shuzhen Guo; Angel T Som; Ken Arai; Eng H Lo
Journal:  Brain Res       Date:  2019-07-26       Impact factor: 3.252

Review 4.  The role of exosomal microRNAs in central nervous system diseases.

Authors:  Yifei Yu; Kun Hou; Tong Ji; Xishu Wang; Yining Liu; Yangyang Zheng; Jinying Xu; Yi Hou; Guangfan Chi
Journal:  Mol Cell Biochem       Date:  2021-01-29       Impact factor: 3.396

5.  Data Standardization and Quality Management.

Authors:  Paul A Lapchak; John H Zhang
Journal:  Transl Stroke Res       Date:  2017-03-10       Impact factor: 6.829

Review 6.  The High Cost of Stroke and Stroke Cytoprotection Research.

Authors:  Paul A Lapchak; John H Zhang
Journal:  Transl Stroke Res       Date:  2016-12-30       Impact factor: 6.829

7.  Telmisartan Inhibits the NLRP3 Inflammasome by Activating the PI3K Pathway in Neural Stem Cells Injured by Oxygen-Glucose Deprivation.

Authors:  Hyuk Sung Kwon; Jungsoon Ha; Ji Young Kim; Hyun-Hee Park; Eun-Hye Lee; Hojin Choi; Kyu-Yong Lee; Young Joo Lee; Seong-Ho Koh
Journal:  Mol Neurobiol       Date:  2021-01-06       Impact factor: 5.590

Review 8.  Protective effects of mesenchymal stem cells on ischemic brain injury: therapeutic perspectives of regenerative medicine.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Cell Tissue Bank       Date:  2020-11-24       Impact factor: 1.522

9.  MiR-126 Affects Brain-Heart Interaction after Cerebral Ischemic Stroke.

Authors:  Jieli Chen; Chengcheng Cui; Xiaoping Yang; Jiang Xu; Poornima Venkat; Alex Zacharek; Peng Yu; Michael Chopp
Journal:  Transl Stroke Res       Date:  2017-01-19       Impact factor: 6.829

10.  Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.

Authors:  Fatemeh Sabbaghziarani; Keywan Mortezaee; Mohammad Akbari; Iraj Ragerdi Kashani; Mansooreh Soleimani; Ashraf Moini; Nahid Ataeinejad; Adib Zendedel; Gholamreza Hassanzadeh
Journal:  Metab Brain Dis       Date:  2016-08-22       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.